Rankings · Quality
Longest A-grade streaks
Graded A at every quarter end of the run and still A today, longest run first. Counted from our point-in-time history, which uses only the filings that were public at each date.
33 companies meet this test
Figures as of October 1, 2026
| # | Company | Grade | Run at A | Revenue growth | Market value |
|---|---|---|---|---|---|
| 1 | VEEVVeeva Systems Inc. | A+ | 40 quarters | — | $46.2B |
| 2 | AZNASTRAZENECA PLC | A+ | 22 quarters | +11% a year | $252.3B |
| 3 | INCYINCYTE CORPORATION | A+ | 21 quarters | — | $24.2B |
| 4 | HALOHALOZYME THERAPEUTICS, INC. | A+ | 13 quarters | +29% a year | $12.5B |
| 5 | PENPenumbra, Inc | A | 11 quarters | +17% a year | $12.5B |
| 6 | UFPTUFP Technologies, Inc. | A+ | 11 quarters | +18% a year | $2.3B |
| 7 | NVSNovartis AG | A | 10 quarters | +70% a year | $272.1B |
| 8 | BMRNBIOMARIN PHARMACEUTICAL INC | A | 10 quarters | +15% a year | $11.6B |
| 9 | VCYTVERACYTE, INC. | A+ | 8 quarters | +20% a year | $3.7B |
| 10 | SYKSTRYKER CORP | A+ | 7 quarters | +10% a year | $105.7B |
| 11 | EXELExelixis Inc | A+ | 7 quarters | +12% a year | $14.5B |
| 12 | KRYSKrystal Biotech, Inc. | A+ | 7 quarters | — | $9.8B |
| 13 | DOCSDoximity, Inc. | A+ | 7 quarters | +14% a year | $5.4B |
| 14 | LFSTLifeStance Health Group, Inc. | A | 7 quarters | +18% a year | $4.6B |
| 15 | SNNSmith & Nephew plc | A | 6 quarters | +6% a year | $11.8B |
| 16 | KNSAKiniksa Pharmaceuticals International, plc | A | 6 quarters | — | $6.1B |
| 17 | ATRCAtriCure, Inc. | A | 6 quarters | +16% a year | $2.9B |
| 18 | MCKMcKESSON CORPORATION | A | 5 quarters | +13% a year | $99.6B |
| 19 | BTSGBrightSpring Health Services, Inc. | A | 5 quarters | +23% a year | $11.2B |
| 20 | GRFSGrifols SA | A | 5 quarters | +7% a year | $5B |
| 21 | HRMYHARMONY BIOSCIENCES HOLDINGS, INC. | A+ | 5 quarters | +24% a year | $2.3B |
| 22 | ALHCALIGNMENT HEALTHCARE, INC. | A | 5 quarters | +41% a year | $1.7B |
| 23 | ANIPANI PHARMACEUTICALS, INC | A+ | 5 quarters | +35% a year | $1.6B |
| 24 | ETONEton Pharmaceuticals, Inc. | A+ | 5 quarters | — | $1.5B |
| 25 | HCSGHEALTHCARE SERVICES GROUP, INC. | A+ | 5 quarters | +4% a year | $1.4B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.